Eric Tse

8.6k total citations · 1 hit paper
111 papers, 4.7k citations indexed

About

Eric Tse is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Eric Tse has authored 111 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 42 papers in Pathology and Forensic Medicine and 39 papers in Molecular Biology. Recurrent topics in Eric Tse's work include Lymphoma Diagnosis and Treatment (39 papers), Viral-associated cancers and disorders (30 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Eric Tse is often cited by papers focused on Lymphoma Diagnosis and Treatment (39 papers), Viral-associated cancers and disorders (30 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Eric Tse collaborates with scholars based in China, Hong Kong and United Kingdom. Eric Tse's co-authors include Yok‐Lam Kwong, Anskar Y.H. Leung, Chor Sang Chim, Terence H. Rabbitts, Seok Jin Kim, Gerry Gin Wai Kwok, Thomas Yau, Joanne Wing Yan Chiu, Chi-Wai Cheng and Roberta Pang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Eric Tse

106 papers receiving 4.6k citations

Hit Papers

PD1 blockade with pembrol... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase
    2017 359 citations Yok‐Lam Kwong, Thomas S. Y. Chan et al. Blood profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eric Tse 2.2k 1.9k 1.5k 1.3k 553 111 4.7k
George Z. Rassidakis 2.4k 1.1× 1.9k 1.0× 1.1k 0.8× 2.4k 1.8× 353 0.6× 140 5.2k
Nalini Janakiraman 1.1k 0.5× 1.5k 0.8× 867 0.6× 1.1k 0.8× 240 0.4× 72 4.3k
Steven H. Bernstein 1.9k 0.9× 1.9k 1.0× 1.7k 1.2× 1.4k 1.1× 242 0.4× 109 5.1k
Elena Ranieri 1.6k 0.7× 448 0.2× 1.6k 1.1× 1.9k 1.5× 476 0.9× 148 5.7k
Xiaoyun Liao 4.3k 2.0× 1.8k 0.9× 934 0.6× 1.5k 1.2× 258 0.5× 69 6.2k
Wei Xu 1.4k 0.6× 1.6k 0.9× 979 0.7× 1.8k 1.3× 249 0.5× 367 4.5k
Didier Bouscary 1.4k 0.7× 821 0.4× 993 0.7× 3.5k 2.6× 532 1.0× 163 6.3k
Jean‐François Rossi 2.9k 1.3× 926 0.5× 1.5k 1.0× 2.7k 2.1× 295 0.5× 110 6.4k
Penelope Korkolopoulou 1.2k 0.5× 925 0.5× 502 0.3× 1.9k 1.4× 372 0.7× 208 4.6k
Muh‐Hwa Yang 2.9k 1.3× 403 0.2× 837 0.6× 4.0k 3.0× 606 1.1× 164 7.6k

Countries citing papers authored by Eric Tse

Since Specialization
Citations

This map shows the geographic impact of Eric Tse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Tse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Tse more than expected).

Fields of papers citing papers by Eric Tse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Tse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Tse. The network helps show where Eric Tse may publish in the future.

Co-authorship network of co-authors of Eric Tse

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Tse. A scholar is included among the top collaborators of Eric Tse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Tse. Eric Tse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Harold, G. Lau, Sze Fai Yip, et al.. (2024). Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone Marrow Transplantation. 59(5). 660–669.
2.
Li, Hongyan, et al.. (2024). Metal-detection based techniques and their applications in metallobiology. Chemical Science. 15(27). 10264–10280. 5 indexed citations
3.
4.
Bogdanović, Andrija, et al.. (2023). P794: EVALUATION OF PEGCETACOPLAN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS WITH APLASTIC ANEMIA IN THE PRINCE STUDY. HemaSphere. 7(S3). e71651d4–e71651d4. 1 indexed citations
5.
Lee, Paul, Rita Yim, Jun Li, et al.. (2022). Epigenetic Silencing of PTEN and Epi-Transcriptional Silencing of MDM2 Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents. International Journal of Molecular Sciences. 23(10). 5670–5670. 2 indexed citations
6.
Tse, Eric & Yok‐Lam Kwong. (2022). Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies. Cancers. 14(3). 597–597. 4 indexed citations
7.
Leung, Garret M. K., Joycelyn Sim, Yu‐Yan Hwang, et al.. (2021). Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre. Annals of Hematology. 101(1). 155–163. 3 indexed citations
8.
Chan, Thomas S. Y., Yu‐Yan Hwang, Pek‐Lan Khong, et al.. (2020). Low‐dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource‐constrained setting. Hematological Oncology. 38(5). 726–736. 23 indexed citations
9.
Cheng, Chi-Wai & Eric Tse. (2020). Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 7. 369–369. 17 indexed citations
10.
11.
Tse, Eric & Yok‐Lam Kwong. (2017). The diagnosis and management of NK/T-cell lymphomas. Journal of Hematology & Oncology. 10(1). 85–85. 208 indexed citations
12.
Chau, David, Thomas S. Y. Chan, Yuen Yee Cheng, et al.. (2015). Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9. Journal of Hematology & Oncology. 8(1). 46–46. 25 indexed citations
13.
Tse, Eric & Yok‐Lam Kwong. (2015). Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target. Experimental & Molecular Medicine. 47(1). e136–e136. 46 indexed citations
14.
Grey, William, Louise Izatt, Caroline Mackie Ogilvie, et al.. (2013). Deficiency of the Cyclin‐Dependent Kinase Inhibitor, CDKN 1 B , Results in Overgrowth and Neurodevelopmental Delay. Human Mutation. 34(6). 864–868. 8 indexed citations
15.
Cheng, Chi-Wai, et al.. (2013). PIN1 Inhibits Apoptosis in Hepatocellular Carcinoma through Modulation of the Antiapoptotic Function of Survivin. American Journal Of Pathology. 182(3). 765–775. 53 indexed citations
16.
Pang, Roberta, Terence K. Lee, Ronnie T. P. Poon, et al.. (2006). Pin1 Interacts With a Specific Serine-Proline Motif of Hepatitis B Virus X-Protein to Enhance Hepatocarcinogenesis. Gastroenterology. 132(3). 1088–1103. 105 indexed citations
17.
Pang, Roberta, Eric Tse, & Ronnie T. P. Poon. (2005). Molecular pathways in hepatocellular carcinoma. Cancer Letters. 240(2). 157–169. 83 indexed citations
18.
19.
Tse, Eric, Andrew J.H. Smith, Stephen P. Hunt, et al.. (2004). Null Mutation of the Lmo4 Gene or a Combined Null Mutation of the Lmo1 / Lmo3 Genes Causes Perinatal Lethality, and Lmo4 Controls Neural Tube Development in Mice. Molecular and Cellular Biology. 24(5). 2063–2073. 72 indexed citations
20.
Tse, Eric, Chi K Yeung, Nigel J. Trendell‐Smith, & Yok‐Lam Kwong. (2002). A cutaneous sore with black eschar in a cowhide worker. The Lancet. 360(9329). 306–306. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Z. Rassidakis Breakdown of academic impact, for papers by Nalini Janakiraman Breakdown of academic impact, for papers by Steven H. Bernstein Breakdown of academic impact, for papers by Elena Ranieri Breakdown of academic impact, for papers by Xiaoyun Liao Breakdown of academic impact, for papers by Wei Xu Breakdown of academic impact, for papers by Didier Bouscary Breakdown of academic impact, for papers by Jean‐François Rossi Breakdown of academic impact, for papers by Penelope Korkolopoulou Breakdown of academic impact, for papers by Muh‐Hwa Yang
Rankless by CCL
2026